HealthPhoto: MintIndia Issues Alert on Counterfeit Defitelio Drug Circulation
India has issued an urgent regulatory alert and deployed drug inspectors nationwide after the WHO warned about a counterfeit batch of Defitelio (defibrotide), used to treat severe hepatic veno-occlusive disease post stem-cell transplantation, circulating illegally. The fake product bears batch number 24GC01A, expiry April 2027, and falsely claims manufacture by Patheon, Italy, and marketing authorization by Gentium S.r.l., Jazz Pharmaceuticals' subsidiary.
Mint·